Literature DB >> 27233898

Is Preoperative Upper Gastrointestinal Endoscopy in Obese Patients Undergoing Bariatric Surgery Mandatory? An Asian Perspective.

June Lee1, Simon Kin-Hung Wong2, Shirley Yuk-Wah Liu2, Enders Kwok-Wai Ng2.   

Abstract

BACKGROUND: The role of routine preoperative oesopha gogastroduodenoscopy (OGD) for all bariatric surgery candidates is controversial. We aim to investigate the prevalence of clinically significant OGD findings in a primarily Chinese obese population and identify factors that predict a normal screening OGD.
METHODS: Medical records of patients who underwent primary bariatric surgery in our centre from August 2002 to December 2014 were reviewed. OGD findings were classified into two groups: group 1 consisted of normal findings and abnormal findings that would not alter the surgical plan; group 2 consisted of lesions that might delay or alter the surgical procedure.
RESULTS: We identified 268 patients (169 female), of mean age 39.1 ± 10.8 years, mean baseline body weight 108.7 ± 6.1 kg and mean body mass index (BMI) 40.3 ± 6.1 kg/m2 for analysis. Overall prevalence of abnormal OGD findings was 51.1 %, which included gastritis (32.5 %), hiatus hernia (17.9 %), duodenitis (8.6 %) and erosive oesophagitis (7.5 %); 27.2 % had group 2 lesions. Univariate analysis revealed older age (p = 0.016), use of NSAIDs (p = 0.004) and presence of reflux symptoms (p = 0.029) as significant risk factors of group 2 lesions. On multivariate analysis, use of NSAIDs (p = 0.015) and reflux symptoms (p = 0.039) remained significant predictive factors. In the low-risk subgroup (40 years and younger, without reflux symptoms or use of NSAIDs), the prevalence of group 2 abnormalities was 18.9 %.
CONCLUSIONS: Significant endoscopic abnormalities are common among obese Chinese patients which may delay or change the surgical plan. The negative predictive value in low-risk patients was not strong. We therefore recommend routine preoperative endoscopy for all patients.

Entities:  

Keywords:  Bariatric surgery; Chinese; Preoperative OGD

Mesh:

Year:  2017        PMID: 27233898     DOI: 10.1007/s11695-016-2243-8

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  35 in total

1.  Bariatric surgery: Asia-Pacific perspective.

Authors:  Wei-Jei Lee; Weu Wang
Journal:  Obes Surg       Date:  2005 Jun-Jul       Impact factor: 4.129

2.  Cancer in the excluded stomach 4 years after gastric bypass.

Authors:  Deborah A Corsini; Celso A M Simoneti; Gisele Moreira; Sizenando E Lima; Arthur B Garrido
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

3.  Is esophagogastroduodenoscopy before Roux-en-Y gastric bypass or sleeve gastrectomy mandatory?

Authors:  Arvid Schigt; Usha Coblijn; Sjoerd Lagarde; Sjoerd Kuiken; Pieter Scholten; Bart van Wagensveld
Journal:  Surg Obes Relat Dis       Date:  2014-01-28       Impact factor: 4.734

4.  IFSO-APC consensus statements 2011.

Authors:  Kazunori Kasama; Wilfred Mui; Wei Jei Lee; Muffazal Lakdawala; Takeshi Naitoh; Yosuke Seki; Akira Sasaki; Go Wakabayashi; Iwao Sasaki; Isao Kawamura; Lilian Kow; Harry Frydenberg; Anton Chen; Mahendra Narwaria; Pradeep Chowbey
Journal:  Obes Surg       Date:  2012-05       Impact factor: 4.129

5.  Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.

Authors:  Hashem B El-Serag; David Y Graham; Jessie A Satia; Linda Rabeneck
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

6.  Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery.

Authors:  M A Küper; T Kratt; K M Kramer; M Zdichavsky; J H Schneider; J Glatzle; D Stüker; A Königsrainer; B L D M Brücher
Journal:  Surg Endosc       Date:  2010-02-05       Impact factor: 4.584

7.  Monitored anesthesia care with propofol versus surgeon-monitored sedation with benzodiazepines and narcotics for preoperative endoscopy in the morbidly obese.

Authors:  Atul K Madan; David S Tichansky; Johnathan Isom; Gayle Minard; Tiffany K Bee
Journal:  Obes Surg       Date:  2008-05       Impact factor: 4.129

8.  Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study.

Authors:  Tolga Erim; Marcia R Cruz-Correa; Samuel Szomstein; Evelio Velis; Raul Rosenthal
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

9.  Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated?

Authors:  Rodrigo Muñoz; Luis Ibáñez; José Salinas; Alex Escalona; Gustavo Pérez; Fernando Pimentel; Sergio Guzmán; Camilo Boza
Journal:  Obes Surg       Date:  2008-09-16       Impact factor: 4.129

10.  Emergency sleeve gastrectomy as rescue treatment for acute gastric necrosis due to type II paraesophageal hernia in an obese woman with gastric banding.

Authors:  Paolo Bernante; Cristiano Breda; Fabio Zangrandi; Fabio Pomerri; Maria Rosa Pelizzo; Mirto Foletto
Journal:  Obes Surg       Date:  2008-04-15       Impact factor: 4.129

View more
  10 in total

1.  Endoscopy Before Laparoscopic Sleeve Gastrectomy.

Authors:  Ali Kagan Coskun
Journal:  Obes Surg       Date:  2019-07       Impact factor: 4.129

Review 2.  Is Routine Preoperative Esophagogastroduodenoscopy Screening Necessary Prior to Laparoscopic Sleeve Gastrectomy? Review of 1555 Cases and Comparison with Current Literature.

Authors:  Asaad Salama; Tamer Saafan; Walid El Ansari; Mohsen Karam; Moataz Bashah
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

Review 3.  Gastrointestinal Symptomatology as a Predictor of Esophagogastroduodenoscopy Findings in the Bariatric Population: a Retrospective Cohort Study with Review of the Literature.

Authors:  Antoine Rioux; Audrey Viger; François-Charles Malo
Journal:  Obes Surg       Date:  2022-05-16       Impact factor: 3.479

4.  Unsedated Transnasal Endoscopy for Preoperative Examination of Bariatric Patients: a Prospective Study.

Authors:  Amaury Teixeira Xavier; Arthur V Alvares; Prasad G Iyer; Vitor N Arantes
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

5.  Does Laparoscopic Sleeve Gastrectomy lead to Barrett's esophagus, 5-year esophagogastroduodenoscopy findings: A retrospective cohort study.

Authors:  Salman Al Sabah; Amina AlWazzan; Khalifa AlGhanim; Hussain A AlAbdulrazzaq; Eliana Al Haddad
Journal:  Ann Med Surg (Lond)       Date:  2021-01-31

6.  Impact of preoperative esophagogastroduodenoscopy in patients undergoing bariatric surgery and development of a model to predict clinically significant abnormal endoscopic findings.

Authors:  Surawitch Sawathanon; Darawan Promchan; Meena Thongwong; Piyanun Wangkulangkul; Siripong Cheewatanakornkul; Suriya Keeratichananont; Kamthorn Yolsuriyanwong
Journal:  Surg Endosc       Date:  2022-07-21       Impact factor: 3.453

7.  Esophagogastroduodenoscopy Findings in Patients on the Waiting List for Bariatric Surgery.

Authors:  Cátia Arieira; Pedro Boal Carvalho; Francisca Dias de Castro; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2019-02-07

8.  Is Routine Preoperative Esophagogastroduodenoscopy Prior to Bariatric Surgery Mandatory? Systematic Review and Meta-analysis of 10,685 Patients.

Authors:  Walid El Ansari; Ayman El-Menyar; Brijesh Sathian; Hassan Al-Thani; Mohammed Al-Kuwari; Abdulla Al-Ansari
Journal:  Obes Surg       Date:  2020-08       Impact factor: 4.129

9.  Role of routine upper endoscopy before bariatric surgery in the Middle East population: a review of 1278 patients.

Authors:  Bassem Abou Hussein; Ali Khammas; Mariam Shokr; Maiyasa Majid; Mariam Sandal; Sameer Al Awadhi; Alya Al Mazrouei; Faisal Badri
Journal:  Endosc Int Open       Date:  2018-10-08

10.  Preoperative Upper-GI Endoscopy Prior to Bariatric Surgery: Essential or Optional?

Authors:  Yusef Moulla; Orestis Lyros; Matthias Mehdorn; Undine Lange; Haitham Hamade; Rene Thieme; Albrecht Hoffmeister; Jürgen Feisthammel; Matthias Blüher; Boris Jansen-Winkeln; Ines Gockel; Arne Dietrich
Journal:  Obes Surg       Date:  2020-06       Impact factor: 4.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.